Your browser doesn't support javascript.
loading
Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies.
Nahas, Stephanie J; Naegel, Steffen; Cohen, Joshua M; Ning, Xiaoping; Janka, Lindsay; Campos, Verena Ramirez; Krasenbaum, Lynda J; Holle-Lee, Dagny; Kudrow, David; Lampl, Christian.
Affiliation
  • Nahas SJ; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. Stephanie.Nahas@jefferson.edu.
  • Naegel S; Department of Neurology, University Hospital Halle (Saale) and University Halle-Wittenberg, Halle, Germany.
  • Cohen JM; Teva Pharmaceutical Industries, West Chester, PA, USA.
  • Ning X; Teva Pharmaceutical Industries, West Chester, PA, USA.
  • Janka L; Teva Pharmaceutical Industries, West Chester, PA, USA.
  • Campos VR; Teva Pharmaceutical Industries, West Chester, PA, USA.
  • Krasenbaum LJ; Teva Pharmaceutical Industries, West Chester, PA, USA.
  • Holle-Lee D; Department of Neurology and Westgerman Headache Center Essen, University Hospital, Essen, Germany.
  • Kudrow D; California Medical Clinic for Headache, Santa Monica, CA, USA.
  • Lampl C; Headache Medical Centre, Linz, Austria.
J Headache Pain ; 22(1): 141, 2021 Nov 24.
Article in En | MEDLINE | ID: mdl-34819017

Full text: 1 Database: MEDLINE Main subject: Migraine Disorders / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans Language: En Journal: J Headache Pain Journal subject: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Migraine Disorders / Antibodies, Monoclonal Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans Language: En Journal: J Headache Pain Journal subject: MEDICINA INTERNA / NEUROLOGIA / PSICOFISIOLOGIA Year: 2021 Type: Article Affiliation country: United States